Status:
UNKNOWN
Exergaming in People With Major Neurocognitive Disorder
Lead Sponsor:
Davy Vancampfort
Conditions:
Randomised Controlled Trial
Major Neurocognitive Disorder
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This randomized controlled trial explores the efficacy of an 8-week standing exergaming program in people with major neurocognitive disorder (MNCD) residing in long-term care facilities.
Detailed Description
This randomized controlled trial explores the efficacy of an 8-week standing exergaming program in people with major neurocognitive disorder (MNCD) residing in long-term care facilities. Fifty inpatie...
Eligibility Criteria
Inclusion
- Inclusion criteria included:
- a Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 diagnosis of MNCD (American Psychiatric Association, 2013)
- aged 65 years or older
- a score of minimum 10 on the Mini-Mental State Examination (MMSE)
- residing at least two weeks in the care facility at the time of inclusion
- being physically capable of doing standing exercises (whether or not with extra support).
- Possible causes of MNCD were vascular dementia, Alzheimer's disease, mixed dementia, Parkinson's disease or Lewy body disease.
- Exclusion criteria consisted of:
- any unstable cardiovascular or other health condition which according to the American College of Sports Medicine Standards might lead to unsafe participation
- a score lower than 10 on the MMSE
- a planned transfer to another setting within the following two months.
Exclusion
Key Trial Info
Start Date :
January 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04436302
Start Date
January 2 2019
End Date
September 30 2020
Last Update
June 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Long-term care facility 'de Wingerd'
Leuven, Vlaams Brabant, Belgium, 3000